Charvi Syal
Ottawa, ON K1H8L6, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Single-cell profiling of brain pericyte heterogeneity following ischemic stroke unveils distinct pericyte subtype-targeted neural reprogramming potential and its underlying mechanisms.
Journal: Theranostics
Published: April 10, 2024
Promising use of metformin in treating neurological disorders: biomarker-guided therapies.
Journal: Neural regeneration research
Published: October 20, 2023
Biomarker-guided drug therapy: personalized medicine for treating Alzheimer's disease.
Journal: Neural regeneration research
Published: March 01, 2021
Metformin promotes CNS remyelination and improves social interaction following focal demyelination through CBP Ser436 phosphorylation.
Journal: Experimental neurology
Published: March 12, 2020
Dysregulated expression of monoacylglycerol lipase is a marker for anti-diabetic drug metformin-targeted therapy to correct impaired neurogenesis and spatial memory in Alzheimer's disease.
Journal: Theranostics
Published: February 15, 2020
Metformin Preconditioning of Human Induced Pluripotent Stem Cell-Derived Neural Stem Cells Promotes Their Engraftment and Improves Post-Stroke Regeneration and Recovery.
Journal: Stem cells and development
Published: June 13, 2018
Ectopic expression of aPKC-mediated phosphorylation in p300 modulates hippocampal neurogenesis, CREB binding and fear memory differently with age.
Journal: Scientific reports
Published: April 17, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026